Tests for genes don’t predict breast cancer better

	Tweet

Studying genes linked to breast cancer may someday lead to better treatments, but they do little to improve a doctor’s ability to predict who is likely to develop a tumor, researchers reported on Wednesday.

Their study in the New England Journal of Medicine found that testing for 10 errant bits of genetic code linked to breast cancer was no better for screening than asking old-fashioned questions involving a woman’s conventional risk factors. These include family history, age of fertility and age when a first child was born.

Only when these questions were combined with genetic testing did the ability to predict a tumor improve. “It was not enough improvement to matter for the great majority of women,” team leader Sholom Wacholder of the National Cancer Institute in Bethesda, Maryland, said in a statement.

The 10 mutations “are not ready to be a kit you can use to make your personal decisions by,” NCI’s Patricia Hartge, who worked on the study, said in a telephone interview.

The study did not look at the BRCA-1 and BRCA-2 breast cancer genes already used to assess cancer risk. Those genes are uncommon but when women have mutated versions they confer a high risk.

The 10 mutations studied are far more common, found in 20 to 40 percent of the population, but each one only seems to increase the risk by a small amount, said Hartge. They are single-letter changes in the genetic code called single-nucleotide polymorphisms or “SNPs”.

After looking at the cases of 11,588 women age 50 to 79, nearly half of whom had been diagnosed with breast cancer, they discovered that testing for the mutations was only slightly better than assessing traditional risk factors.

In addition, among the women whose assessed risk of breast cancer changed as a result of the new test, it did not change enough to affect the way doctors would treat them.

In a commentary, Peter Devilee of Leiden University Medical Center and Matti Rookus of the Netherlands Cancer Institute said it is clear that the 10 breast cancer genes used in the test “are no more than the tip of the iceberg” when it comes to causing cancer.

“For women seeking advice on their personal risk of breast cancer, it is obviously too early to incorporate SNP testing into a counseling procedure, although such tests are already advertised for this purpose on the Internet,” Devilee and Rookus said.

They predicted that will change over the next decade.

The real value of the 10 defects is that one of them might help researchers better understand the cause of breast cancer and lead to better ways to treat it, said Hartge.

“These are 10 new huge clues we didn’t know before to get in and learn what fundamentally causes breast cancer.”

---
By Gene Emery

BOSTON (Reuters)

RELATED STORIES:
Master gene SRC-3 enables breast cancer growth, invasion   Scientists find new gene links to breast cancer   Bone drug works for breast cancer survivors   New Antibody Offers Hope for Treating Ovarian, Breast Cancer   New Treatment Paradigms for Breast Cancer: Managing the Flow of New Data   Breast Cancer Prevention Practices Vary Across Canada   Risk of breast cancer mutations underestimated for Asian women, Stanford study shows   Preschool diet linked to later breast cancer risk   New Way of Expanding Cancer Screening for Minority Women   Drug combo ups breast cancer survival-study   Long-term tamoxifen boosts breast cancer survival   Breast cancer risk tied to grandmother’s diet   Diet may lower breast cancer risk before menopause   New Study Calls for Change In Deciding Frequency of Mammograms   Estrogen Plus Testosterone Therapy May Increase Risk of Breast Cancer   Combination therapy shows improvement for breast cancer patients   Racial differences in severity of breast cancer presentation confirmed   Why Do Some Women Develop Breast Cancer Earlier Than Others?   A new molecular mechanism in breast cancer development   Research Suggests Breast Cancer Fatigue Begins Before Chemo   Fruits, veggies slash breast cancer risk: U.S. study   Certain breast cancer patients worry excessively about recurrence

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]